Deletion Mutants of Francisella Phagosomal Transporters FptA and FptF Are Highly Attenuated for Virulence and Are Protective Against Lethal Intranasal Francisella LVS Challenge in a Murine Model of Respiratory Tularemia
Open Access
Abstract
Francisella tularensis (Ft) is a Gram-negative, facultative intracellular bacterium that is a Tier 1 Select Agent of concern for biodefense for which there is no licensed vaccine. A subfamily of 9 Francisella phagosomal transporter (fpt) genes belonging to the Major Facilitator Superfamily of transporters was identified as critical to pathogenesis and potential targets for attenuation and vaccine development. We evaluated the attenuation and protective capacity of LVS derivatives with deletions of the fptA and fptF genes in the C57BL/6J mouse model of respiratory tularemia. LVSΔfptA and LVSΔfptF were highly attenuated with LD50 values of >20 times that of LVS when administered intranasally and conferred 100% protection against lethal challenge. Immune responses to the fpt mutant strains in mouse lungs on day 6 post-infection were substantially modified compared to LVS and were associated with reduced organ burdens and reduced pathology. The immune responses to LVSΔfptA and LVSΔfptF were characterized by decreased levels of IL-10 and IL-1β in the BALF versus LVS, and increased numbers of B cells, αβ and γδ T cells, NK cells, and DCs versus LVS. These results support a fundamental requirement for FptA and FptF in the pathogenesis of Ft and the modulation of the host immune response.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R01 AI123129, T32 AI095190-08)
This publication has 103 references indexed in Scilit:
- Members of the Francisella tularensis Phagosomal Transporter Subfamily of Major Facilitator Superfamily Transporters Are Critical for PathogenesisInfection and Immunity, 2012
- The major facilitator superfamily (MFS) revisitedThe FEBS Journal, 2012
- Genetic Modification of the O-Polysaccharide of Francisella tularensis Results in an Avirulent Live Attenuated VaccineThe Journal of Infectious Diseases, 2011
- Features of sepsis caused by pulmonary infection with Francisella tularensis Type A strainMicrobial Pathogenesis, 2011
- Infection of Mice with Francisella as an Immunological ModelCurrent Protocols in Immunology, 2011
- Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humansVaccine, 2009
- An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strainVaccine, 2008
- Tuning Microenvironments: Induction of Regulatory T Cells by Dendritic CellsImmunity, 2008
- Molecular immunology of experimental primary tularemia in mice infected by respiratory or intradermal routes with type A Francisella tularensisMolecular Immunology, 2008
- An improved Francisella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routesVaccine, 2008